| Expandable gastroretentive dosage forms EA Klausner, E Lavy, M Friedman, A Hoffman Journal of controlled release 90 (2), 143-162, 2003 | 675 | 2003 |
| N-methylation of peptides: a new perspective in medicinal chemistry J Chatterjee, C Gilon, A Hoffman, H Kessler Accounts of chemical research 41 (10), 1331-1342, 2008 | 640 | 2008 |
| Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs A Dahan, A Hoffman Journal of controlled release 129 (1), 1-10, 2008 | 422 | 2008 |
| Improving oral bioavailability of peptides by multiple N‐methylation: somatostatin analogues E Biron, J Chatterjee, O Ovadia, D Langenegger, J Brueggen, D Hoyer, ... Angewandte Chemie International Edition 47 (14), 2595-2599, 2008 | 405 | 2008 |
| Pharmacodynamic aspects of sustained release preparations A Hoffman Advanced drug delivery reviews 33 (3), 185-199, 1998 | 276 | 1998 |
| The effect of different lipid based formulations on the oral absorption of lipophilic drugs: the ability of in vitro lipolysis and consecutive ex vivo intestinal permeability … A Dahan, A Hoffman European journal of pharmaceutics and biopharmaceutics 67 (1), 96-105, 2007 | 254 | 2007 |
| The solubility–permeability interplay in using cyclodextrins as pharmaceutical solubilizers: mechanistic modeling and application to progesterone A Dahan, JM Miller, A Hoffman, GE Amidon, GL Amidon Journal of pharmaceutical sciences 99 (6), 2739-2749, 2010 | 231 | 2010 |
| Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the … A Dahan, A Hoffman Pharmaceutical research 23, 2165-2174, 2006 | 224 | 2006 |
| Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms A Hoffman, D Stepensky, E Lavy, S Eyal, E Klausner, M Friedman International journal of pharmaceutics 277 (1-2), 141-153, 2004 | 222 | 2004 |
| Intestinal permeability of cyclic peptides: common key backbone motifs identified JG Beck, J Chatterjee, B Laufer, MU Kiran, AO Frank, S Neubauer, ... Journal of the American Chemical Society 134 (29), 12125-12133, 2012 | 215 | 2012 |
| Novel levodopa gastroretentive dosage form: in-vivo evaluation in dogs EA Klausner, S Eyal, E Lavy, M Friedman, A Hoffman Journal of controlled release 88 (1), 117-126, 2003 | 214 | 2003 |
| Modeling of drug release from erodible tablets I Katzhendler, A Hoffman, A Goldberger, M Friedman Journal of pharmaceutical sciences 86 (1), 110-115, 1997 | 201 | 1997 |
| Preclinical evaluation of pharmacokinetic–pharmacodynamic rationale for oral CR metformin formulation D Stepensky, M Friedman, W Srour, I Raz, A Hoffman Journal of controlled release 71 (1), 107-115, 2001 | 199 | 2001 |
| Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs A Dahan, A Hoffman European journal of pharmaceutical sciences 24 (4), 381-388, 2005 | 192 | 2005 |
| Pharmacokinetic-pharmacodynamic analysis of the glucose-lowering effect of metformin in diabetic rats reveals first-pass pharmacodynamic effect D Stepensky, M Friedman, I Raz, A Hoffman Drug Metabolism and Disposition 30 (8), 861-868, 2002 | 171 | 2002 |
| The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides O Ovadia, S Greenberg, J Chatterjee, B Laufer, F Opperer, H Kessler, ... Molecular pharmaceutics 8 (2), 479-487, 2011 | 170 | 2011 |
| Pharmacokinetic considerations of new insulin formulations and routes of administration A Hoffman, E Ziv Clinical pharmacokinetics 33, 285-301, 1997 | 169 | 1997 |
| Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability P Gershkovich, A Hoffman European journal of pharmaceutical sciences 26 (5), 394-404, 2005 | 166 | 2005 |
| Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects I Cherniakov, AJ Domb, A Hoffman Expert opinion on drug delivery 12 (7), 1121-1133, 2015 | 165 | 2015 |
| A peptide prodrug approach for improving bisphosphonate oral absorption A Ezra, A Hoffman, E Breuer, IS Alferiev, J Mönkkönen, ... Journal of medicinal chemistry 43 (20), 3641-3652, 2000 | 159 | 2000 |
